Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 30% ± 13% | |
oligodendrocyte | 11 studies | 31% ± 11% | |
astrocyte | 10 studies | 30% ± 14% | |
glutamatergic neuron | 9 studies | 47% ± 25% | |
oligodendrocyte precursor cell | 9 studies | 29% ± 12% | |
fibroblast | 7 studies | 25% ± 11% | |
GABAergic neuron | 7 studies | 49% ± 21% | |
interneuron | 6 studies | 46% ± 25% | |
macrophage | 6 studies | 25% ± 5% | |
microglial cell | 6 studies | 24% ± 5% | |
retinal cone cell | 6 studies | 28% ± 9% | |
adipocyte | 6 studies | 21% ± 5% | |
neuron | 5 studies | 30% ± 13% | |
epithelial cell | 5 studies | 27% ± 11% | |
granule cell | 4 studies | 23% ± 6% | |
retinal rod cell | 4 studies | 24% ± 2% | |
endothelial cell of lymphatic vessel | 4 studies | 25% ± 5% | |
pericyte | 4 studies | 24% ± 9% | |
smooth muscle cell | 4 studies | 21% ± 1% | |
GABAergic interneuron | 3 studies | 28% ± 2% | |
cardiac muscle cell | 3 studies | 18% ± 2% | |
GABAergic amacrine cell | 3 studies | 22% ± 8% | |
amacrine cell | 3 studies | 20% ± 4% | |
glycinergic amacrine cell | 3 studies | 21% ± 4% | |
type II pneumocyte | 3 studies | 19% ± 6% | |
lymphocyte | 3 studies | 23% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1347.27 | 1445 / 1445 | 100% | 14.75 | 183 / 183 |
lung | 100% | 1404.93 | 578 / 578 | 100% | 14.63 | 1155 / 1155 |
ovary | 100% | 1691.46 | 180 / 180 | 100% | 9.84 | 430 / 430 |
prostate | 100% | 1379.18 | 245 / 245 | 100% | 16.69 | 502 / 502 |
brain | 100% | 1575.86 | 2639 / 2642 | 100% | 17.88 | 705 / 705 |
breast | 100% | 1566.56 | 459 / 459 | 100% | 17.48 | 1116 / 1118 |
uterus | 100% | 1569.25 | 170 / 170 | 100% | 14.20 | 457 / 459 |
intestine | 100% | 1424.27 | 966 / 966 | 99% | 12.21 | 524 / 527 |
thymus | 100% | 1378.75 | 653 / 653 | 99% | 13.70 | 601 / 605 |
bladder | 100% | 1397.33 | 21 / 21 | 99% | 11.61 | 500 / 504 |
pancreas | 100% | 699.57 | 327 / 328 | 99% | 11.93 | 177 / 178 |
kidney | 100% | 982.49 | 89 / 89 | 98% | 12.72 | 879 / 901 |
stomach | 100% | 1059.46 | 359 / 359 | 98% | 12.68 | 279 / 286 |
skin | 100% | 1746.44 | 1809 / 1809 | 95% | 15.05 | 447 / 472 |
adrenal gland | 100% | 1358.61 | 258 / 258 | 93% | 7.65 | 214 / 230 |
liver | 100% | 632.14 | 226 / 226 | 88% | 6.50 | 358 / 406 |
adipose | 100% | 1644.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1491.99 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.13 | 29 / 29 |
muscle | 100% | 1111.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1164.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.87 | 1 / 1 |
heart | 97% | 724.67 | 833 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 71% | 6.10 | 57 / 80 |
peripheral blood | 53% | 595.18 | 495 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000209 | Biological process | regulation of anoikis |
GO_0010469 | Biological process | regulation of signaling receptor activity |
GO_0006621 | Biological process | protein retention in ER lumen |
GO_0005737 | Cellular component | cytoplasm |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ANKRD13C |
Protein name | Ankyrin repeat domain-containing protein 13C |
Synonyms | |
Description | FUNCTION: Acts as a molecular chaperone for G protein-coupled receptors, regulating their biogenesis and exit from the ER. . |
Accessions | ENST00000370944.9 [Q8N6S4-1] ENST00000262346.6 [Q8N6S4-2] Q8N6S4 |